ACH
ACCENDRA HEALTH INC/VA/
Next earnings Aug 10, 2026 (before open) · consensus $-0.09 EPS, $634M rev
Last earnings +8.7% on 2026-05-11
$3.34
▲ 0.00%$3.34▼ -54.12%
over 1Y
L $1.91EODHDH $9.42
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.0%
1W+4.4%
1M+18.4%
3M+59.8%
YTD+44.0%
1Y-54.1%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Sell
Conservative balance sheet (liabilities/equity -6.32x); but unprofitable (net margin -39.8%).
Revenue (FY2025) $2.76B · FY2025
ACCENDRA HEALTH INC/VA/ shows $2.76B in FY2025 revenue (+3.1% YoY), a -39.8% net margin.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $9.79B | $9.96B | $2.55B | $2.68B | $2.76B |
| Gross profit | $1.51B | $1.83B | $2.13B | $2.22B | — |
| Operating income | $368M | $143M | $133M | -$218M | $27.5M |
| Net income | $222M | $22.4M | -$41.3M | -$363M | -$1.10B |
| Diluted EPS | $2.94 | $0.29 | -$0.53 | -$4.73 | -$14.31 |
| Net margin | 2.3% | 0.2% | -1.6% | -13.5% | -39.8% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$1.21B
EV / EBITDA5.0
EV / Sales0.4
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-431.1%
FCF yield-114.7%
Quality & risk
ROIC (est.)—
Free cash flow-$293M
Total debt$1.24B
Net cash-$954M
Altman Z-Score0.40 distress
Piotroski F-Score4/9
Capital returns
Buyback yield4.0%
Dividend yield (est.)0.0%
Shareholder yield4.0%
Shares Δ YoY-1.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-232026-06-25open ↗8-KPeriod ending 2026-06-092026-06-15open ↗SDFiling2026-05-29open ↗8-KPeriod ending 2026-05-222026-05-22open ↗4Period ending 2026-05-182026-05-20open ↗4Period ending 2026-05-152026-05-19open ↗4Period ending 2026-05-152026-05-19open ↗4Period ending 2026-05-152026-05-19open ↗4Period ending 2026-05-152026-05-19open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗
Frequently asked
- Is ACCENDRA HEALTH INC/VA/ (ACH) a buy?
- ACH currently carries a Avoid rating with 3/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity -6.32x); but unprofitable (net margin -39.8%).
- What is ACCENDRA HEALTH INC/VA/'s quality score?
- ACH scores 45.23529411764706/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000075252, latest 10-Q filed 2026-05-11) · EODHD · as of 6/26/2026, 7:05:59 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.